Telomir Pharmaceuticals, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 1.27 M | $5.23 M | 10.18% | 4.29% |
| BLACKROCK, INC. | 02/07/2025 | 1.06 M | $4.35 M | 188.10% | 3.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 413,677 | $1.70 M | 73.28% | 1.40% |
| NORTHERN TRUST CORP | 02/14/2025 | 151,628 | $624,707 | 211.48% | 0.51% |
| SUNCOAST EQUITY MANAGEMENT | 02/03/2025 | 51,194 | $210,919 | 0.00% | 0.17% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 50,530 | $208,184 | 100.00% | 0.17% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 46,406 | $191,193 | 327.71% | 0.16% |
| MORGAN STANLEY | 02/14/2025 | 40,221 | $165,710 | 251.15% | 0.14% |
| BARCLAYS PLC | 02/13/2025 | 29,959 | $123,000 | 326.89% | 0.10% |
| 02/13/2025 | 28,803 | $118,668 | 100.00% | 0.10% | |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 24,990 | $102,959 | 100.00% | 0.08% |
| CITIGROUP INC | 02/12/2025 | 15,236 | $62,772 | 337.06% | 0.05% |
| ATOM INVESTORS LP | 02/14/2025 | 15,017 | $61,870 | 100.00% | 0.05% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 14,959 | $62,000 | 100.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 14,713 | $60,618 | 283.85% | 0.05% |
| BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 02/10/2025 | 14,623 | $60,247 | 0.00% | 0.05% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 11,796 | $49,000 | 0.00% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 10,699 | $44,080 | 279.40% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 9,613 | $39,606 | 273.76% | 0.03% |
| RHUMBLINE ADVISERS | 01/30/2025 | 8,600 | $35,425 | 105.94% | 0.03% |
| GOTHAM ASSET MANAGEMENT, LLC | 02/14/2025 | 6,770 | $228,555 | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 2,355 | $9,703 | 57.21% | 0.01% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 1,938 | $7,985 | 158.40% | 0.01% |
| FMR LLC | 02/13/2025 | 1,393 | $5,739 | 867.36% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 02/13/2025 | 471 | $1,941 | 0.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 269 | $1,108 | 2,590.00% | 0.00% |
| AMALGAMATED BANK | 02/04/2025 | 166 | $1,000 | 0.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 132 | $544 | 100.00% | 0.00% |
| 02/06/2025 | 3 | $12 | 100.00% | 0.00% | |
| JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| CAPITAL PERFORMANCE ADVISORS LLP | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Telomir Pharmaceuticals, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Telomir Pharmaceuticals, Inc. Common Stock. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.27 M
BlackRock, Inc.: 1.06 M
GEODE CAPITAL MANAGEMENT, LLC: 413,677
NORTHERN TRUST CORP: 151,628
GOLDMAN SACHS GROUP INC: 50,530
CHARLES SCHWAB INVESTMENT MANAGEMENT INC: 46,406
11.66% of Telomir Pharmaceuticals, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 3.29 M shares in the last 24 months. This purchase volume represents approximately $8.39 M in transactions.